Lenabasum reduces IFN gamma and pIRF3 in dermatomyositis skin: Biomarker results from a double-blind phase 3 international randomized controlled trialT. Vazquez,M. Sharma, R. Feng,D. Diaz,N. Kodali, J. Dan,M. Grinnell,E. Keyes, G. Sprow,B. White, V. WerthJOURNAL OF INVESTIGATIVE DERMATOLOGY（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
